Multiple studies have observed a stimulating effect of UBE2T protein on the progression of HCC through the promotion of proliferation [49], cell migration [50], or epithelial–mesenchymal transition (EMT) [51], using HepG2 as a model. Here, UBE2T is linked to hepatocellular carcinoma.